Previous Article | Next Article ![]()
Infection and Immunity, February 2001, p. 1009-1015, Vol. 69, No. 2
Departments of Microbiology & Molecular
Genetics and Medicine, University of California Irvine, Irvine,
California 92697,1 and Department of
Microbiology, University of Texas Health Science Center, San
Antonio, Texas 287402
Received 5 June 2000/Returned for modification 3 August
2000/Accepted 27 September 2000
The antigenic variation of the relapsing fever agent Borrelia
hermsii is associated with changes in the expression of the Vlp
and Vsp outer membrane lipoproteins. To investigate whether these
serotype-defining proteins are the target of a neutralizing and
protective antibody response, monoclonal antibodies were produced from
spleens of infected mice just after clearance of serotype 7 cells from
the blood. Two immunoglobulin M monoclonal antibodies, H7-7 and H7-12,
were studied in detail. Both antibodies specifically agglutinated
serotype 7 cells and inhibited their growth in vitro. Administered to
mice before or after infection, both antibodies provided protection
against infection or substantially reduced the number of spirochetes in
the blood of mice after infection. Whereas antibody H7-12 bound to Vlp7
in Western blotting, enzyme-linked immunosorbent assay, and
immunoprecipitation assays, as well as to whole cells in other
immunoassays, antibody H7-7 only bound to wet, intact cells of serotype
7. Antibody H7-7 selected against cells expressing Vlp7 in vitro and in
vivo, an indication that Vlp7 was a conformation-sensitive antigen for
the antibody. Vaccination of mice with recombinant Vlp7 with adjuvant
elicited antibodies that bound to fixed whole cells of serotype 7 and
to Vlp7 in Western blots, but these antibodies did not inhibit the
growth of serotype 7 in vitro and did not provide protection against an
infectious challenge with serotype 7. The study established that a Vlp
protein was the target of a neutralizing antibody response, and it also indicated that the conformation and/or the native topology of Vlp were
important for eliciting that immunity.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.1009-1015.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vitro and In Vivo Neutralization of the Relapsing Fever
Agent Borrelia hermsii with Serotype-Specific
Immunoglobulin M Antibodies
*
Corresponding author. Mailing address: Department of
Microbiology & Molecular Genetics, University of California, Irvine, CA
92660. Phone: (949) 824-5626. Fax: (949) 824-8598. E-mail: abarbour{at}uci.edu.
Present address: ManorCare Health Services, 550 S. Carlin
Springs Rd., Arlington, VA 20024.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|